首页> 美国卫生研究院文献>Clinical and Experimental Immunology >Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens peritoneal exudate cells containing tumour tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell lines
【2h】

Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens peritoneal exudate cells containing tumour tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell lines

机译:实体瘤标本含有肿瘤的腹膜渗出细胞肿瘤浸润淋巴细胞(TIL)衍生的T细胞系和已建立的肿瘤细胞系在人上皮性卵巢癌中细胞因子转录本的差异表达

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

T cell lines derived in low concentrations of recombinant IL-2 (rIL-2) from TIL of patients with epithelial ovarian carcinoma (EOC) often exhibit specific cytotoxicity against autologous tumour cells. However, the ability of T cells at the tumour site to respond to ovarian carcinoma cells may be affected by the production of cytokines by the various cell types present. Using reverse transcriptase-polymerase chain reaction (RT-PCR) we investigated cytokine transcripts in: (i) established EOC tumour cell lines; (ii) solid tumour specimens or peritoneal exudate cells (PEC) from ascites or peritoneal washings of patients with EOC; and (iii) CD4+ TCRαβ+ and CD8+ TCRαβ+ TIL-derived T cell lines developed in rIL-2. We have found that (i) established EOC tumour cell lines expressed transcripts for transforming growth factor-beta 2 (TGF-β2) (7/7), but not IL-10 (0/7) or interferon-gamma (IFN-γ) (0/7) and rarely IL-2 (1/7); (ii) PEC expressed transcripts for IL-2 (12/13), IL-10 (9/13), and TGF-β2 (12/13), and less often, IFN-γ (3/13), whereas solid tumour specimens from eight patients with EOC expressed transcripts for IL-2 (4/8), TGF-β2 (4/8), and IL-10 (5/8), but not for IFN-γ (0/8); (iii) CD4+ TCRαβ+ T cell lines expressed transcripts for IFN-γ (4/4), IL-2 (4/4) and IL-10 (3/4), whereas CD8+ TCRαβ+ T cell lines expressed transcripts for IFN-γ (5/5), IL-2 (1/5) and IL-10 (2/5). None of these T cell lines expressed TGF-β2 transcripts. The frequency of IL-2 and TGF-β2 transcripts in solid tumours was significantly lower than in the PEC (P = 0.0475). CD4+ or CD8+ T cell lines expressing IFN-γ, IL-2 and IL-10 transcripts were derived in culture with rIL-2 from the TIL of specimens that did not necessarily express these cytokines in the absence of rIL-2. The frequency of cytokine transcripts in T cell lines compared with these same transcripts in the PEC was significantly higher for IFN-γ (P = 0.0005) and lower for TGF-β2 (P = 0.0001). An association was observed between the expression of cytokine transcripts in vivo or by TIL-derived cell lines and functions exhibited by either production of cytokines or in vitro cytotoxicity.
机译:来自上皮性卵巢癌(EOC)患者TIL的低浓度重组IL-2(rIL-2)衍生的T细胞系通常表现出对自体肿瘤细胞的特异性细胞毒性。然而,存在的各种细胞类型可通过细胞因子的产生来影响肿瘤部位的T细胞对卵巢癌细胞的反应能力。使用逆转录酶-聚合酶链反应(RT-PCR),我们调查了以下细胞因子的转录本:(i)已建立的EOC肿瘤细胞系; (ii)患有EOC的患者的腹水或腹膜冲洗液的实体瘤标本或腹膜渗出细胞(PEC); (iii)CD4 + TCRαβ + 和CD8 + TCRαβ + TIL衍生的T细胞系在rIL中发育-2。我们发现(i)已建立的EOC肿瘤细胞系表达的转录本可转化生长因子-β2(TGF-β2)(7/7),但不表达IL-10(0/7)或干扰素-γ(IFN-γ) )(0/7)和IL-2(1/7)很少; (ii)PEC表达IL-2(12/13),IL-10(9/13)和TGF-β2(12/13)的转录本,而IFN-γ(3/13)的转录本较少,来自八名EOC患者的肿瘤标本表达IL-2(4/8),TGF-β2(4/8)和IL-10(5/8)的转录本,但不表达IFN-γ(0/8)的转录本; (iii)CD4 + TCRαβ + T细胞系表达IFN-γ(4/4),IL-2(4/4)和IL-10(3)的转录本/ 4),而CD8 + TCRαβ + T细胞系表达IFN-γ(5/5),IL-2(1/5)和IL-10的转录本(2/5)。这些T细胞系均未表达TGF-β2转录本。实体瘤中IL-2和TGF-β2转录物的频率显着低于PEC(P = 0.0475)。用IFN-γ,IL-2和IL-10转录本表达CD4 + 或CD8 + T细胞系,并用rIL-2从标本的TIL中培养。在没有rIL-2的情况下不一定表达这些细胞因子。与PEC中相同的转录本相比,T细胞系中细胞因子转录本的频率对于IFN-γ显着更高(P = 0.0005),而对于TGF-β2则更低(P = 0.0001)。在体内或TIL衍生的细胞系中观察到细胞因子转录物的表达与细胞因子产生或体外细胞毒性所表现出的功能之间存在关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号